| Long Term Administration of Inhaled Mannitol in Cystic Fibrosis (NCT00630812) | Syntara | 2008-09-01 |
| Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic Fibrosis (NCT00737100) | Boehringer Ingelheim | 2008-09-01 |
| Intraduodenal Aspiration Study to Assess the Bioavailability of Oral Pancrecarb® Compared to Placebo Control (NCT00744250) | Digestive Care, Inc. | 2008-08-01 |
| Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency (NCT00743483) | Swedish Orphan Biovitrum | 2008-08-01 |
| A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency (NCT00662675) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2008-08-01 |
| Miglustat in Cystic Fibrosis (NCT00742092) | Actelion | 2008-08-01 |
| Early Assessment of Respiratory Function, Inflammation and Bronchial Reshuffle Among Newborns Screened for Cystic Fibrosis (NCT02883816) | University Hospital, Montpellier | 2008-08-01 |
| Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa (NCT00757237) | Gilead Sciences | 2008-08-01 |
| Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease (NCT00659529) | National Jewish Health | 2008-08-01 |
| Transfer Impedance in Cystic Fibrosis (NCT00743158) | Boston Children's Hospital | 2008-08-01 |
| Leucine-enriched Essential Amino Acid Intake to Optimize Protein Anabolism in Children With Cystic Fibrosis (NCT01172301) | Texas A&M University | 2008-07-01 |
| Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis (NCT00706004) | University of Arkansas | 2008-07-01 |
| Exercise-Induced Bronchospasm in Cystic Fibrosis (NCT00806455) | Ohio State University | 2008-07-01 |
| Dissection of Staphylococcus Aureus Infection From Colonization in Cystic Fibrosis Patients (NCT00669760) | University Hospital Muenster | 2008-07-01 |
| Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF) (NCT00690820) | Solvay Pharmaceuticals | 2008-06-01 |
| Do Physiotherapy Techniques Improve Posture During Admission for a Chest Infection in Adults With Cystic Fibrosis? (NCT00806884) | Royal Brompton & Harefield NHS Foundation Trust | 2008-06-01 |
| A Study of Pulmozyme® (Dornase Alpha) in 3- to 5-Year-Old Patients With Cystic Fibrosis (NCT00680316) | Genentech, Inc. | 2008-06-01 |
| IGF-1 Therapy in Patients With Cystic Fibrosis (NCT00566241) | Stony Brook University | 2008-06-01 |
| Comparison of Airway Clearance Therapy in Cystic Fibrosis Using the Same VEST Therapy Device But With Different Settings (NCT00685035) | University of Minnesota | 2008-05-01 |
| Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa (NCT00712166) | Gilead Sciences | 2008-05-01 |
| Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis (NCT00645788) | Bayer | 2008-05-01 |
| Scandinavian Cystic Fibrosis Azithromycin Study (NCT00411736) | Rigshospitalet, Denmark | 2008-05-01 |
| Changes in Adherence After Playing "My Life With CF" Game (NCT00688051) | Children's Mercy Hospital Kansas City | 2008-05-01 |
| Study About Complications of Totally Implanted Venous Access Devices (TIVADs) in People With Cystic Fibrosis (CF) (NCT00670579) | University of Florence | 2008-05-01 |
| Doxycycline Effects on Inflammation in Cystic Fibrosis (NCT01323101) | University of Southern California | 2008-04-01 |
| Nutritional, Metabolic and Respiratory Status in Cystic Fibrosis (NCT00476281) | University Hospital, Strasbourg, France | 2008-04-01 |
| 18FDG-PET Imaging to Detect Changes in Airways Inflammation in Cystic Fibrosis Patients (NCT00684346) | The Hospital for Sick Children | 2008-04-01 |
| Comprehensive Exercise Training Program During Hospitalization for an Acute CF Exacerbation (NCT01759342) | University of Alabama at Birmingham | 2008-04-01 |
| Modulation by Sex Hormones of Inflammation and Susceptibility to Pseudomonas Aeruginosa in Cystic Fibrosis Airways (NCT00700050) | The Hospital for Sick Children | 2008-04-01 |
| Vitamin D3 for the Treatment of Low Vitamin D in Cystic Fibrosis (NCT00762918) | Children's Hospital of Philadelphia | 2008-03-01 |
| Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas Aeruginosa (NCT00638365) | Humanigen, Inc. | 2008-03-01 |
| NPD Measurement in Infants (NCT00564304) | Hadassah Medical Organization | 2008-03-01 |
| Self-dispersing Liquids as Aerosol Drug Carriers (NCT00628134) | University of Pittsburgh | 2008-03-01 |
| The Effect of Hypertonic Saline on the Lung Clearance Index in Patients With Cystic Fibrosis (NCT00635141) | The Hospital for Sick Children | 2008-03-01 |
| Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease (NCT00625612) | Merck Sharp & Dohme LLC | 2008-02-01 |
| SD Cystic Fibrosis Study (NCT00605761) | GlaxoSmithKline | 2008-02-01 |
| Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies (NCT00727285) | National Jewish Health | 2008-02-01 |
| Time to Perform Lung Function Test in Cystic Fibrosis (NCT01737801) | Karolinska University Hospital | 2008-02-01 |
| Effect of Proton Pump Inhibitors on CF Pulmonary Exacerbations (NCT01983774) | Columbia University | 2008-02-01 |
| Effect of Pioglitazone on Inflammation in Cystic Fibrosis (NCT00719381) | Paul Beringer | 2008-01-01 |
| Segmentation of Structural Abnormalities in Chronic Lung Diseases (NCT04760548) | Hôpital Haut Lévêque | 2008-01-01 |
| Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa (NCT00558844) | Insmed Incorporated | 2008-01-01 |
| Biodistribution of Neutrophile Proteases in the Sputum of Patients Affected by Cystic Fibrosis (NCT00750932) | University Hospital, Tours | 2008-01-01 |
| The Effect of rhDNase on Ventilation Inhomogeneity in Patients With Cystic Fibrosis (NCT00557089) | The Hospital for Sick Children | 2008-01-01 |
| Cystic Fibrosis Foundation (CFF) Biomarkers of Exacerbation (NCT00788359) | University of Colorado, Denver | 2007-12-01 |
| Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis (NCT00510484) | Solvay Pharmaceuticals | 2007-11-01 |
| Structure and Function of Salivary Proteins (NCT00916682) | Boston Children's Hospital | 2007-11-01 |
| Miglustat / OGT 918 in the Treatment of Cystic Fibrosis (NCT00537602) | Actelion | 2007-11-01 |
| Effect of Lubiprostone on Nutritional Status and Pulmonary Function in Adults With Cystic Fibrosis (NCT00577499) | University of Arkansas | 2007-10-01 |
| Absorptive Clearance in the Cystic Fibrosis Airway (NCT00541190) | University of Pittsburgh | 2007-10-01 |
| Using Rheological Methods to Characterize Cystic Fibrosis (CF) Sputum and the Effects of Mucoactive Agents (NCT00758771) | University of California, San Francisco | 2007-10-01 |
| Treatment of Aspergillus Fumigatus (a Fungal Infection) in Patients With Cystic Fibrosis (NCT00528190) | Ottawa Hospital Research Institute | 2007-10-01 |
| Choline Nutrition in Children With Cystic Fibrosis (NCT01070446) | University of British Columbia | 2007-10-01 |
| Microbial Community Composition and Dynamics in Lungs of Cystic Fibrosis Sibling Pairs (NCT00590330) | Boston Children's Hospital | 2007-10-01 |
| Lancovutide (Moli1901) Inhalation Solution Study in Adolescents and Adults With Cystic Fibrosis (NCT00671736) | AOP Orphan Pharmaceuticals AG | 2007-10-01 |
| Choline Nutritional Status Of Children With Cystic Fibrosis X-Sectional Study (NCT01150136) | University of British Columbia | 2007-10-01 |
| Coping Compliance and Adjustment in Adolescents With Cystic Fibrosis (NCT00577252) | Akron Children's Hospital | 2007-10-01 |
| Choline Nutrition in Children With Cystic Fibrosis (CF) (NCT00686361) | University of British Columbia | 2007-10-01 |
| Pilot Mouthwash Study of Pioglitazone and Simvastatin in Healthy Volunteers (NCT00531882) | University Hospitals Cleveland Medical Center | 2007-09-01 |
| Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients (NCT00499837) | Kamada, Ltd. | 2007-09-01 |
| Evaluation of the Emission Distance of P. Aeruginosa From the Respiratory Tract of People With Cystic Fibrosis (NCT00531531) | University of Florence | 2007-09-01 |
| Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis (NCT00221546) | University Hospital, Ghent | 2007-09-01 |
| Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis (NCT00546663) | CF Therapeutics Development Network Coordinating Center | 2007-09-01 |
| Nasal Inhalation of Pulmozyme in Patients With Cystic Fibrosis and Chronic Rhinosinusitis (NCT00534079) | University of Jena | 2007-09-01 |
| Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung Disease (NCT00425165) | Merck Sharp & Dohme LLC | 2007-08-01 |
| Safety and Efficacy of an Antioxidant-rich Multivitamin Supplement in Cystic Fibrosis (NCT01018303) | University of Colorado, Denver | 2007-08-01 |
| Hypertonic Saline and Mucociliary Clearance in Children (NCT01293084) | Johns Hopkins University | 2007-07-01 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis (NCT00506792) | Novartis Pharmaceuticals | 2007-07-01 |
| Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI) (NCT00513682) | Forest Laboratories | 2007-07-01 |
| Efficacy and Safety Study of Inhaled Glutathione in Cystic Fibrosis Patients (NCT00506688) | Mukoviszidose Institut gGmbH | 2007-07-01 |
| Sleep in Patients With Cystic Fibrosis (NCT00804661) | Assistance Publique - Hôpitaux de Paris | 2007-07-01 |
| Disclosing a Cystic Fibrosis Diagnosis to a Dating Partner (NCT00485082) | National Human Genome Research Institute (NHGRI) | 2007-06-05 |
| Open-Label Phase III Long-Term Safety Trial of Liprotamase (NCT00449904) | Anthera Pharmaceuticals | 2007-06-01 |
| Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis (NCT00503490) | Amgen | 2007-06-01 |
| Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency (NCT00449878) | Anthera Pharmaceuticals | 2007-05-01 |
| Safety Study of Ivacaftor in Subjects With Cystic Fibrosis (NCT00457821) | Vertex Pharmaceuticals Incorporated | 2007-05-01 |
| A Study of Ataluren in Pediatric Participants With Cystic Fibrosis (NCT00458341) | PTC Therapeutics | 2007-03-23 |
| A Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects With Severe Lung Disease (TOPIC) (NCT00434278) | Genentech, Inc. | 2007-03-01 |
| Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study (NCT00446680) | Syntara | 2007-03-01 |
| Prolonging the Duration of Peripheral Venous Catheters in Cystic Fibrosis People (NCT00418470) | University of Florence | 2007-03-01 |
| Do Musculoskeletal Techniques Improve Forced Expiratory Volume in One Second in Adults With Cystic Fibrosis? (NCT00716664) | Royal Brompton & Harefield NHS Foundation Trust | 2007-03-01 |
| Exercise Training Study for Patients With Cystic Fibrosis (NCT00609050) | University of Pittsburgh | 2007-03-01 |
| Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™) (NCT00777296) | Insmed Incorporated | 2007-02-22 |
| Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa (NCT00431964) | CF Therapeutics Development Network Coordinating Center | 2007-02-01 |
| Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI (NCT00406536) | Avanti Polar Lipids, Inc. | 2007-01-01 |
| Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis (NCT00432861) | Digestive Care, Inc. | 2007-01-01 |
| Airway Clearance Using High Frequency Chest Wall Oscillation (NCT00817947) | Royal Brompton & Harefield NHS Foundation Trust | 2007-01-01 |
| Utility of Induced Sputum Using Hypertonic Saline to Evaluate Infection and Inflammation in Cystic Fibrosis (NCT00721071) | The Hospital for Sick Children | 2006-12-01 |
| PTC124 for the Treatment of Cystic Fibrosis (NCT00351078) | PTC Therapeutics | 2006-12-01 |
| Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis (NCT00547053) | Boston Children's Hospital | 2006-12-01 |
| Nasally Delivered Pulmozyme for Sinusitis in Cystic Fibrosis (NCT00416182) | University of Vermont | 2006-12-01 |
| Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI) (NCT00408317) | Forest Laboratories | 2006-11-01 |
| Improving Vitamin D Status In Cystic Fibrosis (NCT00450073) | Atlanta VA Medical Center | 2006-11-01 |
| The Short Term Safety and Efficacy of Inhaled L-arginine in Patients With Cystic Fibrosis (NCT00405665) | The Hospital for Sick Children | 2006-11-01 |
| Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease (NCT00368446) | National Heart, Lung, and Blood Institute (NHLBI) | 2006-10-17 |
| Anti-Inflammatory Pulmonal Therapy of CF-Patients With Amitriptyline and Placebo (NCT00515229) | University Hospital Tuebingen | 2006-10-01 |
| Assessment of Quadriceps Muscle Electrostimulation Used in Patients Suffering From Cystic Fibrosis (NCT00391703) | University Hospital, Grenoble | 2006-10-01 |
| Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary Exacerbations (NCT00381628) | University Hospitals Cleveland Medical Center | 2006-09-01 |
| Evaluation of a Decision Aid for Adult Cystic Fibrosis Patients Considering Bilateral Lung Transplantation (NCT00345449) | Ottawa Hospital Research Institute | 2006-09-01 |
| Safety, Tolerability and Pharmacokinetics of Tiotropium in Cystic Fibrosis Patients (NCT02172534) | Boehringer Ingelheim | 2006-09-01 |